Decisions 23rd February 2016


At the meeting that took place on 23rd February 2016, the folllowing decisions were agreed.

 

New Drug Requests

Approved

Ceftolozane & Tazobactam (Zerbaxa®) (TLS Red)

  • Approved for inclusion onto the formulary for patients with multi-drug resistant gram negative pathogens.

Rivaroxaban (TLS Red)

  • Approved for inclusion onto the formulary for DVT prophylaxis in patients post limb fracutre and immobilisation.

Cangrelor (TLS Red)

  • Approved for inclusion onto the formulary for adult patients with coronary artery disease undergoing percutanous coronary intervention who have not received an oral P2Y12 inhibitor prior to the PCI procedure and in whom oral therapy with P2Y12 inhibitors is not feasibile or desirable.

Idarucizumab (TLS Red)

  • Approved for inclusion onto the formulary as a specific reversal agent for dabigatran.

 

Not Approved

Alirocumab

  • The JFG did not approve the addition of Alirocumab onto the formulary.  The JFG acknowledged the negative NICE ACD and shared the concerns around outcomes and cost-effectiveness at this time and therefore felt it was advisable to wait until national guidance was issued by NICE.

More information required

Rituximab for autoimmune haemolytic anaemia

  • The JFG requested more information in relation to the costs involved in implementing this treatment option.

 

Shared Care Protocols/TLS Change in Status

Vortioxetine

  • Agreed for TLS Red until SCP written and agreed.  To be prescribed in accordance with the NICE TA.

  

Ciclosporin eye drops

  • Agreed for TLS Red.

  

Atomoxetine

  • New SCP presented.  For further comments/discussion.  To be brought back to next meeting for sign off.

 

Methotrexate SCP (Dermatology)

  • New SCP presented.  For further comments/discussion.  To be brought back to next meeting for sign off.

 

Azathioprine SCP (Dermatology)

  • New SCP presented.  For further comments/discussion.  To be brought back to next meeting for sign off.

Alfacalcidol Prescribing guidance

  • New prescribing guidance agreed.

Sevelamer SCP

  • SCP reviewed and updated.  The JFG approved the updated version.  

 

Donepezil, galantamine, memantine and Rivastigmine SCPs

  • Updated SCPs presented.  To be brought back to next JFG with additional comments and for sign off.

  

 

Last updated by: on 03-05-2016 12:36